No Gimmicks.
Just Science.

“The present invention solves the foregoing problems by providing a mixture of three compounds, which together can mitigate the neuronal injury caused by… aberrant cerebral perfusion states. In one of the many preferred embodiments, these compounds can include Phosphocreatine (PCr), Magnesium Gluconate (MgG) and beta-hydroxybutyrate (BHB). Together these three compounds synergistically protect the brain, the blood vessels, and the blood brain barrier. For convenience purposes, the mixture of compounds may be referred to herein as "TCP.”

“The neuroprotective mixture of the present invention, with its multidimensional and synergistic mechanisms of action coupled with its prophylactic/preventative administration strategy, represents a significant departure from previous attempts at neuroprotection.”

“Evidence also demonstrates that TCP can reduce disruption to the blood brain barrier following an ischemic insult. Blood brain barrier extravasation studies utilizing Evan's Blue dye demonstrated a significant decrease in extravasation within groups receiving the invention alone as well as a synergistic effect in animals receiving both the invention and tPA.”

“This neuroprotective mixture represents a novel approach to neuroprotection in several respects. First, the neuroprotective mixture is a combination of three separate classes of chemical compounds that favorably affect major adverse events involved in neuronal death. Together these three classes of compounds create a tri-functional neuroprotective system that protects the brain, the blood vessels, and the blood brain barrier. These classes of chemical compounds have several mechanisms of action, which when combined in the proper ratio, yield surprisingly good results. This represents a significant departure from earlier neuroprotective trials that were one-dimensional in nature.”